Today, the U.S. House of Representatives, in a 217-215 vote, passed the Limit, Save, Grow Act, advancing provisions that would greatly restrict access to affordable care and risk progress in the fight against cancer.
Last year, the U.S. Food and Drug Administration (FDA) released its proposed rules to eliminate menthol cigarettes and eliminate all flavors in cigars. Now, nearly one year later, the rules are still not final. This inaction has allowed Big Tobacco to continue targeting these products to the Black community, who consistently reports the highest prevalence of menthol cigarette use.
Today, the American Cancer Society Cancer Action Network (ACS CAN) sent a letter to Speaker Kevin McCarthy and House Democratic Leader Hakeem Jeffries detailing concerns on provisions in the Limit, Save and Grow Act that would restrict access to affordable health care and risk progress in cancer research.
ACS CAN joined 32 patient and provider groups 33 organizations applauding the Supreme Court’s decision to pause new restrictions that would have limited access to the FDA-approved drug mifepristone while litigation about the drug works its way through the courts.
According to multiple news reports, President Biden has nominated Monica M. Bertagnolli, MD, to serve as the Director of the National Institutes of Health (NIH).
This morning, House Speaker Kevin McCarthy proposed concepts to address the debt limit that would jeopardize Americans’ access to meaningful, affordable health care by implementing work requirements for the Medicaid health insurance program and threaten federally-funded cancer research by shrinking discretionary spending.
Patient groups representing millions of people with serious health conditions released a statement today to thank the DOJ for requesting a stay in the ruling of the Braidwood v. Becerra case, which threatens coverage of USPSTF recommended preventive services without cost sharing as required under the ACA.
Attorneys General for six states and DC today announced a $462 million multi-state settlement to be paid out by JUUL Labs, following an investigation into its underage marketing practices to attract youth to its addictive e-cigarettes.
Our organizations, representing patients with serious health conditions, condemn Judge Kacsmaryk’s decision which threatens to restrict access to a Food and Drug Administration (FDA)- approved medication and other treatments.
More than a dozen patient groups representing millions of Americans with serious and chronic health conditions are urging the U.S. Court of Appeals for the Fifth Circuit to preserve protections in the Affordable Care Act (ACA) for Lesbian, Gay, Bisexual, Transgender and Queer (LGBTQ+) patients receiving health care services in the case of Neese vs. Becerra.